Please assess the completion status of the following clinical trial:

Trial Title: Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Macular oedema due to retinal vein occlusion~Exclusion Criteria:~* Not living in metropolitan France

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Ozurdex® (dexamethasone intravitreal implant) (Type: None): dexamethasone intravitreal implant 700 μg administered into the eye according to physician judgment.

Based on this trial design, predict the completion outcome and termination type (if applicable).